|Articles|April 15, 2003
Cyclosporine emulsion offers severe dry eye relief
April 14-San Francisco-Cyclosporine ophthalmic emulsion 0.05% drops (Restasis,Allergan), approved 11 days ago, offers relief of dry eye symptoms by treatingthe inflammatory process that causes the condition, explained John D. Sheppard,MD, program and laboratory director, professor, departments of ophthalmologyand pharmacology, Eastern Virginia School of Medicine. He spoke during thesymposium, "Interdisciplinary Perspectives in Corneal Health Integrity,"sponsored by Allergan.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
MeiraGTx Licenses complement-targeted geographic atrophy program from ZipBio
2
Metformin use associated with reduced incidence of intermediate AMD
3
Last year in glaucoma at EnVision Summit 2025
4
Looking back at the 2025 EnVision Summit
5
























